Intrinsic Value of S&P & Nasdaq Contact Us

Cross Country Healthcare, Inc. CCRN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
$1,894.95
+19295.6%
Analyst Price Target
$10.61
+8.6%

Cross Country Healthcare, Inc. (CCRN) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $9.77. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of CCRN = $1,894.95 (+19295.6% from the current price, the stock appears undervalued). Analyst consensus target is CCRN = $11 (+8.6% upside).

Valuation: CCRN trades at a trailing Price-to-Earnings (P/E) of -3.2 (S&P 500 average ~25).

Financials: revenue is $1.1B, -27.7%/yr average growth. Net income is $95M (loss), growing at -244.4%/yr. Net profit margin is -9% (negative). Gross margin is 18.7% (-3.7 pp trend).

Balance sheet: total debt is $2M against $323M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.78 (strong liquidity). Debt-to-assets is 0.5%. Total assets: $449M.

Analyst outlook: 4 / 14 analysts rate CCRN as buy (29%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 67/100 (Partial), Moat 25/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).

$10.61
▲ 8.6% Upside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Cross Country Healthcare, Inc., the average price target is $10.61, with a high forecast of $14.00, and a low forecast of $8.65.
Highest Price Target
$14.00
Average Price Target
$10.61
Lowest Price Target
$8.65

CCRN SharesGrow Score Overview

41/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 78/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 25/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CCRN

VALUE Pass
78/100
CCRN trades at a trailing Price-to-Earnings (P/E) of -3.2 (S&P 500 average ~25). Forward PEG -0.02 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.01. Analyst consensus target is $11, implying +12.6% from the current price $10. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Fail
15/100
CCRN: -27.7%/yr revenue is, -244.4%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
CCRN: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet CCRN: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 3.78 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
25/100
CCRN: Gross margin is 18.7% (-3.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 25/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 4 / 14 analysts rate CCRN as buy (29%). Analyst consensus target is $11 (+12.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
10/100
CCRN: Net profit margin is -9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range7.43-15.01
Volume221.74K
Avg Volume (30D)506.85K
Market Cap$315.75M
Beta (1Y)0.34
Share Statistics
EPS (TTM)-2.93
Shares Outstanding$32.41M
IPO Date2001-10-25
Employees9,605
CEOKevin Cronin Clark
Financial Highlights & Ratios
Revenue (TTM)$1.05B
Gross Profit$196.78M
EBITDA$13.33M
Net Income$-94.85M
Operating Income$-3.46M
Total Cash$108.74M
Total Debt$2.32M
Net Debt$-106.42M
Total Assets$448.95M
Price / Earnings (P/E)-3.3
Price / Sales (P/S)0.3
Analyst Forecast
1Y Price Target$10.50
Target High$14.00
Target Low$8.65
Upside+7.5%
Rating ConsensusHold
Analysts Covering14
Buy 29% Hold 71% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS2274831047

Price Chart

CCRN
Cross Country Healthcare, Inc.  ·  NASDAQ Global Select
Healthcare • Medical - Care Facilities
7.43 52WK RANGE 15.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message